🇳🇱
Western EuropeNetherlands
The Netherlands is a rising biotech hub with strength in gene therapy and infectious disease. The Leiden Bio Science Park and Amsterdam Science Park anchor the ecosystem.
Biotech Market Cap
$67.3B
Public Companies
11
Total Companies
201
30D Performance
-0.38%
BIOTECH MARKET CAP INDEX
$67.3B+17362.5%ALL
BIOTECH HUBS
AmsterdamLeidenUtrechtGroningen
COMPANIES
| # | Company | Valuation |
|---|---|---|
| 1 |  | $49.0B |
| 2 |  | $6.8B |
| 3 |  | $4.7B |
| 4 | | $3.8B |
| 5 |  | $2.0B |
| 6 |  | $1.5B |
| 7 |  | $1.4B |
| 8 |  | $909.7M |
| 9 |  | $459.9M |
| 10 |  | $227.7M |
| 11 |  | $181.3M |
| 12 |  | $164.4M |
| 13 |  | — |
| 14 |  | — |
| 15 |  | — |
| 16 |  | — |
| 17 |  | — |
| 18 |  | — |
| 19 |  | — |
| 20 |  | — |
1–20 of 201
Page 1 of 11